We are live on ! Find out more
NUVB.WS

Nuvation Bio Inc Warrants

Delisted

NUVB.WS was delisted on the 10th of February, 2026.

23 hedge funds and large institutions have $18M invested in Nuvation Bio Inc Warrants in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.44% less ownership

Funds ownership: 25.41%22.97% (-2.4%)

13% less capital invested

Capital invested by funds: $20.7M → $18M (-$2.75M)

15% less funds holding

Funds holding: 2723 (-4)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5

Holders
23
Holders Change
-4
Holders Change %
-14.81%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
5
Closed
5
Calls
$98K
Puts
Net Calls
+$98K
Net Calls Change
+$14K
Name Holding Trade Value Shares
Change
Change in
Stake
EC
1
EcoR1 Capital
California
$8.97M
6CM
2
683 Capital Management
New York
$2.15M
HCM
3
Highbridge Capital Management
New York
$889K
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$693K
BC
5
Boxer Capital
California
$693K
Franklin Resources
6
Franklin Resources
California
$693K
BlackRock
7
BlackRock
New York
$608K
CCA
8
Castle Creek Arbitrage
Colorado
$579K
DM
9
Deerfield Management
New York
$433K
RSCM
10
Rock Springs Capital Management
Maryland
$348K
APM
11
Avidity Partners Management
Texas
$260K
GC
12
Greenlight Capital
New York
$260K
ACP
13
Acuta Capital Partners
California
$236K -$8.15K -2,500 -3%
CAM
14
Cormorant Asset Management
Massachusetts
$217K
Citadel Advisors
15
Citadel Advisors
Florida
$192K
Victory Capital Management
16
Victory Capital Management
Texas
$179K
LGM
17
Logos Global Management
California
$173K
MA
18
MYDA Advisors
New York
$99K -$6.52K -2,000 -5%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$91K -$1.39K -426 -1%
MIM
20
Monashee Investment Management
Massachusetts
$69K
IP
21
Intellectus Partners
California
$69K +$86.1K +26,414 New
CAC
22
Cowen and Company
New York
$68K -$66.2K -20,304 -44%
UBS Group
23
UBS Group
Switzerland
$10K -$16.5K -5,053 -57%
Walleye Capital
24
Walleye Capital
New York
$424
Wellington Management Group
25
Wellington Management Group
Massachusetts
-$614K -229,835 Closed

NUVB.WS Hedge Fund Activity: Q2 2021 in Review

23 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q2 2021, worth a combined $18M — down 13% from $20.7M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of NUVB.WS and 1 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 0 added.

The largest buyer was Intellectus Partners, opening a new position worth an estimated $86.1K. The largest seller was Wellington Management Group, exiting entirely with an estimated $614K sold.

  • 23 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q2 2021, down from 27 in Q1 2021.
  • Funds reported $18M of Nuvation Bio Inc Warrants stock for Q2 2021, down 13% quarter-over-quarter.
  • 1 fund opened new Nuvation Bio Inc Warrants positions in Q2 2021 and 5 closed out, a net change of -4 holders.
  • The largest Nuvation Bio Inc Warrants buyer in Q2 2021 was Intellectus Partners, an estimated $86.1K added.
  • The largest Nuvation Bio Inc Warrants seller in Q2 2021 was Wellington Management Group, an estimated $614K sold.

Based on aggregated 13F filings for Q2 2021.